extending observations on the presence of streptococcal antibodies in human sera from rheumatic fever patients, showed that sera from patients with 'rheumatic arthritis' contained antibodies to cellular antigens of Group A Type 12 streptococci. These patients had sensitised sheep cell agglutination titres between 1:160 and 1:5120 as measured by the method of Rose et al. (1948) and hence presumably correspond to patients with clinical rheumatoid arthritis. An examination of synovial fluids from patients with rheumatoid arthritis (RA) for the presence of antibody to Group A streptococci seemed to be of interest in the light of these results.
Materials and methods

SYNOVIAL FLUID
Fluid was obtained from patients with, (a) classical or definite rheumatoid arthritis (ARA criteria), (b) uncomplicated osteoarthrosis (OA), and, (c) other connective tissue disease.
Fluids were treated with hyaluronidase (B.D.H., 0-1 mg/ml) at 37°C overnight and then centrifuged. The supernatant was submitted to immunodiffusion. All the fluids used were free from blood, as judged by eye.
Accepted for publication October 27, 1977 ANTIGEN PREPARATIONS A Lancefield acidic extract was prepared from a nephritogenic streptococcal strain, Group A Type 12, by the method given by Cruickshank (1965) . This was used in most of the experiments. In certain experiments corresponding extracts from other Group A streptococci and streptococci of Groups B, C, D, and G were prepared in a similar manner. The streptococci were supplied by Mr W. Marr, Department of Bacteriology, University of Edinburgh.
Four strains of diphtheroid organisms isolated from the synovial fluid of rheumatoid arthritis patients (Stewart et al., 1969) were similarly extracted with acid. These organisms were supplied by Dr S. M. Stewart, Department of Bacteriology, University of Edinburgh.
Streptococcal (Group A Type 12) polysaccharidemucopeptide complex prepared from purified cell walls was a gift from Dr Heymann and Ms Manniello of Ciba-Geigy.
IMMUNODIFFUSION
Immunodiffusion was carried out as described by Clausen (1969) 
Results
Initially synovial fluids were examined by immunodiffusion against a Lancefield extract of Group A Type 12 streptococci. Tested in this way 83 3% of synovial fluids from rheumatoid arthritis patients gave a positive precipitin reaction; none of the osteoarthrosis fluids was positive (Table) . When sera from a further 19 RA patients were also tested by immunodiffusion, in parallel with corresponding synovial fluids, only 6 of the 19 serum samples reacted positively whereas 14 of the 19 fluids gave a positive result. Four osteoarthrosis cases gave negative results both with serum and synovial fluid. The material reacting with the streptococcal antigen, therefore, seemed to be mainly in the synovial fluid of patients with rheumatoid arthritis. This was confirmed by immunodiffusion and immunoelectrophoresis. Fibrinogen (2 % Kabi) gave a clear precipitin line with the Group A Type 12 streptococcal extract. In order to obtain a photographic record (Fig. 1 ) of the fusion of this arc with that between a synovial fluid and the streptococcal extract it was necessary to concentrate the streptococcal extract and the synovial fluid to about half volume. Fig. 2 shows the reactions of the antiserum to the synovial fluid component with synovial fluid and with fibrinogen. Fusion of the arcs again occurred. The reactions of identity with a commercial anti-fibrinogen serum (Hoechst Pharmaceuticals) and the antiserum to the synovial fluid component against a synovial fluid are shown in Fig. 3 and against fibrinogen in Fig. 4 . Immunoelectrophoresis of synovial fluid confirmed that the reacting material had the characteristics of fibrinogen.
Absorption experiments further confirmed the identification: (1) fibrinogen added to the antiserum against the synovial fluid component removed the appropriate antibody, (2) addition of fibrinogen to the streptococcal antigen extract removed the material reacting with synovial fluid, and (3) after addition of sufficient fibrinogen antiserum to synovial fluid the synovial fluid no longer reacted with the streptococcal extract nor the antiserum prepared against the synovial fluid component. Controls for all experiments were carried out in parallel adding saline. Fibrinogen (and/or some of its degradation products) was obviously the reactive material in the synovial fluids.
Immunodiffusion studies on synovial fluid from patients with rheumatoid arthritis 341 Fibrinogen was treated with streptokinase (as varidase): with 10 min treatment at 370C the reaction with the streptococcal extract was still retained. Treatment for 60 min or longer destroyed the reactivity to the streptococcal extract, although the antiserum (to the synovial fluid) still reacted positively as did the anti-fibrinogen antiserum.
The addition of streptococcal antigen extract to the antiserum raised in rabbits did not remove the antibody to fibrinogen and in fact the antiserum only rarely showed a very faint and doubtful positive precipitin band with the streptococcal extract. The antibody was obviously mainly, if not entirely, directed against the fibrinogen part of the streptococcal antigen-fibrinogen complex.
The material in the streptococcal extract reacting with fibrinogen was further studied. Immunodiffusion showed that it was not the same as that which reacted with the commercial anti Group A streptococcal serum (Wellcome). Also when cell wall mucopeptide was tested, at levels from 5 ,ug/ml to 20 mg/ml against several fluids which reacted against the streptococcal extract, no positive reaction was obtained with any fluid and the presence of Nacetyl glucosamine in the agar gel did not inhibit the formation of precipitin lines. N-acetyl glucosamine (1 %) inhibits the raction between the Group specific polysaccharide and the corresponding antibody (Braun and Holm, 1970) .
The acidic extracts of other streptococci gave no precipitin bands when tested against synovial fluids with the exception of one Group C organism which had been isolated from a mid-stream urine specimen (Royal Infirmary, Edinburgh). The organisms tested were 2 other Group A, 4 Group B, 4 Group C, 1 Group D, and 1 Group G streptococci.
No reaction was obtained with any of the diphtheroid organisms and synovial fluids.
Discussion
Braun and Holm (1970) detected antibodies to Group A streptococci in 66% of the sera examined from rheumatoid arthritis patients and in only 6% of a control group. With synovial fluids we found that 86-3 % of RA patients reacted positively to a Lancefield extract of Group A streptococci and in that respect our results appeared to agree with those of Braun and Holm (1970) using serum samples. However, the reactive species in the Lancefield extract is not the Group A specificpoly saccharide and the component in the synovial fluid involved in the immunodiffusion reaction appears to be fibrinogen (or a closely related molecule). There may, of course, be antibodies to Group A specific carbohydrate in the serum and it is noticeable that 31 -6 % of the RA serum samples reacted positively to the Lancefield streptococcal extract but only 18 * 2 % of these samples reacted with the much more sensitive antiserum.
The material in the Lancefield extract is not the same as that which reacts with the streptococcal Group A antiserum; a conclusion confirmed by the lack of reaction of Group A cell-wall polysaccharidemucopeptide complex with synovial fluiids. The fact that other Group A streptococci tested did not react with synovial fluids suggests the possibility that the reacting material may be the type specific M protein. This material is extractable in acid along with the Group polysaccharide (Cruickshank, 1965) .
The component in the synovial fluid which reacted with the streptococcal extract appeared to be fibrinogen and/or possibly the material detected by Schur and Sandson (1963) and designated r2F. Beta 2F is produced from fibrinogen by treatment with streptokinase for 10 min; fibrinogen specimens treated in this way still retained activity.
Attempts to implicate streptococci in rheumatoid arthritis have been made in the past but the nonspecificity of the results have usually been acknowledged in the end (see Gardner, 1972) . The observation that fibrinogen can give a sharp precipitin band in immunodiffusion experiments with streptococcal extracts also indicates another source of confusion in attempts to implicate streptococci in the aetiology of rheumatoid arthritis.
It is, however, of interest that, of the streptococci tested, only the Group A Type 12 and a Group C organism gave extracts which reacted positively against synovial fluids and fibrinogen. Whether this indicates that a suitable M-protein could react with fibrinogen in vivo and initiate some adverse reaction remains to be studied. Certainly, in that case, one might expect to find evidence for a M-protein or a fibrinogen-M-protein complex in RA synovial fluids and not in fluids from OA patients. Barnhart et al. (1971) have suggested that fibrinogen, fibrin, and their proteolysis products may play a part in the inflammatory process, and they showed that fibrinogen-derived polypeptides increased vascular permeability in rabbits and guinea pigs. Fibrinogen has also been shown to be present in increased amounts in inflammatory synovial fluids (Takeda, 1967) and has been used as an indicator of the degree of inflammation. Fibrinogen may, therefore, have some fundamental role in the inflammatory process and any alteration, for example by combination with a streptococcal component, could be of major importance.
A final speculation is that the fibrinogenstreptococcal M-protein could be treated by the body as a foreign protein and, in this way, be the stimulus for the inflammatory reaction. Various substances, including streptococci (Stein et al., 1973; Svartz, 1976) , and proteins (Consden et al., 1971) 
